Genomictree Inc. (KOSDAQ: 228760)
South Korea
· Delayed Price · Currency is KRW 17,000
+800 (4.94%)
Sep 12, 2024, 11:33 AM KST
Genomictree Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -9,564 | -8,756 | -6,631 | -11,425 | -11,795 | -10,195 | Upgrade
|
| Depreciation & Amortization | 1,167 | 1,178 | 1,335 | 1,022 | 907.92 | 490.49 | Upgrade
|
| Loss (Gain) From Sale of Assets | 4.46 | - | -8.5 | -17.1 | -8.45 | 0.35 | Upgrade
|
| Loss (Gain) From Sale of Investments | 534.06 | 328.33 | 2,097 | 2,072 | -728.2 | 219.14 | Upgrade
|
| Stock-Based Compensation | 730.78 | 1,633 | 249.51 | 694.04 | 402.47 | 1,015 | Upgrade
|
| Provision & Write-off of Bad Debts | 188.53 | 188.53 | 2,064 | - | - | - | Upgrade
|
| Other Operating Activities | -3,857 | -3,909 | 7,075 | 764.11 | 2,252 | 212.72 | Upgrade
|
| Change in Accounts Receivable | -3,237 | -6,688 | -636.9 | -1,362 | -100.58 | -34.99 | Upgrade
|
| Change in Inventory | 280.6 | 54.74 | -303.82 | 1,000 | -964.78 | -266.53 | Upgrade
|
| Change in Accounts Payable | 3,492 | 3,501 | 154.42 | -728.24 | -142.42 | 156.8 | Upgrade
|
| Change in Unearned Revenue | -0.68 | -9.17 | -3 | 13.19 | 14.83 | -0.5 | Upgrade
|
| Change in Other Net Operating Assets | -3,056 | 1,597 | -1,106 | 335.58 | -80.68 | -364.31 | Upgrade
|
| Operating Cash Flow | -13,316 | -10,881 | 4,286 | -7,631 | -10,243 | -8,767 | Upgrade
|
| Capital Expenditures | -2,460 | -239.08 | -1,762 | -10,963 | -2,683 | -2,242 | Upgrade
|
| Sale of Property, Plant & Equipment | 1 | - | 21.36 | 52.89 | 8.45 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -54.03 | -49.32 | -61.64 | -865.31 | -98.87 | -268.33 | Upgrade
|
| Investment in Securities | -49,100 | 5,522 | 13,459 | -41,774 | 13,656 | -61,934 | Upgrade
|
| Other Investing Activities | 3,487 | 2,885 | 2,412 | 4,478 | 3,428 | 4,951 | Upgrade
|
| Investing Cash Flow | -48,126 | 8,119 | 14,069 | -49,072 | 14,311 | -59,494 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 50,191 | 13,145 | 800 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -500 | Upgrade
|
| Long-Term Debt Repaid | - | -54.3 | -14,534 | -2,242 | -167.52 | -24.12 | Upgrade
|
| Total Debt Repaid | -51.76 | -54.3 | -14,534 | -2,242 | -167.52 | -524.12 | Upgrade
|
| Net Debt Issued (Repaid) | -51.76 | -54.3 | -14,534 | 47,949 | 12,977 | 275.88 | Upgrade
|
| Issuance of Common Stock | - | - | - | 4,996 | - | 103,490 | Upgrade
|
| Repurchase of Common Stock | - | - | -4,984 | - | - | - | Upgrade
|
| Other Financing Activities | 6,055 | -20,443 | -6.21 | 0 | -0.31 | 0.85 | Upgrade
|
| Financing Cash Flow | 6,003 | -20,497 | -19,525 | 62,869 | 12,977 | 103,767 | Upgrade
|
| Foreign Exchange Rate Adjustments | 431.44 | 402.28 | 2,280 | 3,654 | -3,303 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -55,007 | -22,856 | 1,110 | 9,820 | 13,741 | 35,506 | Upgrade
|
| Free Cash Flow | -15,775 | -11,120 | 2,523 | -18,593 | -12,926 | -11,009 | Upgrade
|
| Free Cash Flow Margin | -773.93% | -325.32% | 8.45% | -361.76% | -1043.37% | -3909.18% | Upgrade
|
| Free Cash Flow Per Share | -668.12 | -419.50 | 120.20 | -900.62 | -646.74 | -576.03 | Upgrade
|
| Cash Interest Paid | - | - | - | 45.45 | 32.43 | 19.4 | Upgrade
|
| Cash Income Tax Paid | - | -73.91 | 2,096 | 473.01 | -500.16 | 599.4 | Upgrade
|
| Levered Free Cash Flow | -15,075 | -29,381 | 20,761 | -22,739 | -8,544 | -8,269 | Upgrade
|
| Unlevered Free Cash Flow | -14,833 | -28,097 | 24,125 | -19,860 | -7,501 | -8,269 | Upgrade
|
| Change in Net Working Capital | 4,942 | 19,633 | -22,861 | 3,533 | -1,912 | 670.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.